which today might not be a factor anymore as NEO is now cheaper by more than a third. As I already mentioned, the main reason for the company's stock price falling is their top-line miss.

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 34.8% in ... 34.1% from previous close. The stock market overreacts to news, and big price drops can present good ...

NEO Infracon, operating in the Construction, Contracting & Engineering sector and classified as a Smallcap on the BSE, currently has its share price at ₹25.9. The stock has experienced ...

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 34.8% in the afternoon ... down 34.1% from previous close. The stock market overreacts to news, and big price drops can ...

When your smartphone quest involves navigating the treacherous terrain between blistering performance and a price tag that ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...